Victory Capital Management
PRTK

Victory Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Victory Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,782
Closed -$40K – 3470
2020
Q1 		$40K Buy
+12,782
New +$47.2K ﹤0.01% 2862
2019
Q4 		– Sell
-4,961
Closed -$21K – 3455
2019
Q3 		$21K Buy
+4,961
New +$19.8K ﹤0.01% 3030
2017
Q4 		– Sell
-31,610
Closed -$793K – 1845
2017
Q3 		$793K Sell
31,610
-680
-2% -$15.8K ﹤0.01% 1262
2017
Q2 		$778K Sell
32,290
-450
-1% -$9.95K ﹤0.01% 1231
2017
Q1 		$630K Buy
+32,740
New +$516K ﹤0.01% 1258

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's PRTK Position: Q2 2020 in Review

Victory Capital Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2020, closing a stake of 12,782 shares — an estimated $40K sold.

Victory Capital Management first reported a position in PRTK in Q1 2017 and held it in 5 quarters. The position peaked at $793K in Q3 2017. 99 funds tracked by Wall St. Rank hold PRTK as of Q2 2020.

  • Victory Capital Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 12,782 Paratek Pharmaceuticals, Inc. shares in Q2 2020, an estimated $40K.
  • Victory Capital Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 5 quarters.
  • Victory Capital Management's Paratek Pharmaceuticals, Inc. position peaked at $793K in Q3 2017.
  • 99 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.